PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation

FASEB Journal

Volumn 21, Issue 10, 2007, Pages 2335-2342

  Deshpande, Deepak A ^a   Pascual, Rodolfo M ^a   Wang, Si Wei ^a   Eckman, Delrae M ^a   Riemer, Ellen C ^a   Funk, Colin D ^b   Penn, Raymond B ^a,c  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Airway smooth muscle; Cysteinyl leukotriene; Desensitization; G protein coupled receptor; Protein kinase C

Indexed keywords

CYSTEINYLLEUKOTRIENE TYPE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE D4; MONOCYTE CHEMOTACTIC PROTEIN; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CALCIUM TRANSPORT; CELL FUNCTION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DESENSITIZATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; INTRACELLULAR SPACE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION;

ANIMALS; CALCIUM; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; HUMANS; INHALATION; LEUKOTRIENES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MONOCYTES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHOSPHATIDYLINOSITOLS; POLYMERASE CHAIN REACTION; PROTEIN KINASE C; RECEPTORS, LEUKOTRIENE; TRACHEA;

MURINAE;

EID: 34547768330     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-8060com     Document Type: Article

References (37)

1. Beller, T. C., Friend, D. S., Maekawa, A., Lam, B. K., Austen, K. F., and Kanaoka, Y. (2004) Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc. Natl. Acad. Sci. U. S. A. 101, 3047-3052
2. Austen, K. F. (2005) The mast cell and the cysteinyl leukotrienes. Novartis. Found. Symp. 271, 166-175
3. Funk, C. D. (2005) Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat. Rev. Drug. Discov. 4, 664-672
4. Metters, K. M., Gareau, Y., Lord, A., Rochette, C., and Sawyer, N. (1994) Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung. J. Pharmacol. Exp. Ther. 270, 399-406
5. Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D. S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789-793
6. Naik, S., Billington, C. K., Pascual, R. M., Deshpande, D. A., Stefano, F. P., Kohout, T. A., Eckman, D. M., Benovic, J. L., and Penn, R. B. (2005) Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J. Biol. Chem. 280, 8722-8732
7. Penn, R. B., and Benovic, J. L. (1998) Regulation of G protein-coupled eceptors. In Handbook of Physiology (Conn, P. M., Ed.). Oxford Univ. Press, New York, pp 125-164
8. Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R. A., Bond, R. A., Milano, C. A., and Lefkowitz, R. J. (1995) Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268, 1350-1353
9. Rockman, H. A., Choi, D. J., Akhter, S. A., Jaber, M., Giros, B., Lefkowitz, R. J., Caron, M. G., and Koch, W. J. (1998) Control of myocardial contractile function by the level of beta- adrenergic receptor kinase 1 in gene-targeted mice. J. Biol. Chem. 273, 18180-18184
10. Rockman, H. A., Chien, K. R., Choi, D. J., Iaccarino, G., Hunter, J. J., Ross, J., Jr., Lefkowitz, R. J., and Koch, W. J. (1998) Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc. Natl. Acad. Sci. U. S. A. 95, 7000-7005
11. Penn, R. B., Pronin, A. P., and Benovic, J. L. (2000) Regulation of G protein-coupled receptor kinases. Trends. Cardiovasc. Med. 10, 81-89
12. Yang, G., Haczku, A., Chen, H., Martin, V., Galczenski, H., Tomer, Y., Van Besien, C. R., Evans, J. F., Panettieri, R. A., and Funk, C. D. (2004) Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L992-L1001
13. Panettieri, R. A., Murray, R. K., DePalo, L. R., Yadvish, P. A., and Kotlikoff, M. I. (1989) A human smooth muscle cell line that retains physiological responsiveness. Am. J. Physiol. Cell Physiol. 256, C329-C335
14. Deshpande, D. A., White, T. A., Guedes, A. G., Milla, C., Walseth, T. F., Lund, F. E., and Kannan, M. S. (2005) Altered airway responsiveness in CD38-deficient mice. Am. J. Respir. Cell Mol. Biol. 32, 149-156
15. Loza, M. J., Foster, S., Peters, S. P., and Penn, R. B. (2006) Beta-agonists modulate T cell functions via direct actions on type 1 and type 2 cells. Blood 107, 2052-2060
16. Thivierge, M., Stankova, J., and Rola-Pleszczynski, M. (2001) IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J. Immunol. 167, 2855-2860
17. Figueroa, D. J., Breyer, R. M., Defoe, S. K., Kargman, S., Daugherty, B. L., Waldburger, K., Liu, Q., Clements, M., Zeng, Z., O'Neill, G. P., et al. (2001) Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care. Med. 163, 226-233
18. Thivierge, M., Stankova, J., and Rola-Pleszczynski, M. (2006) Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells. J. Allergy. Clin. Immunol. 117, 1155-1162
19. Ichiyama, T., Hasegawa, M., Ueno, Y., Makata, H., Matsubara, T., and Furukawa, S. (2005) Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages. Clin. Exp. Allergy. 35, 1214-1219
20. 2+ is essential for the development of cerebral vasospasm. Curr. Vasc. Pharmacol. 2, 13-21
21. Murphy, S., and Frishman, W. H. (2005) Protein kinase C in cardiac disease and as a potential therapeutic target. Cardiol. Rev. 13, 3-12
22. Harnett, K. M., Cao, W., and Biancani, P. (2005) Signal-transduction pathways that regulate smooth muscle function I. Signal transduction in phasic (esophageal) and tonic (gastroesophageal sphincter) smooth muscles. Am. J. Physiol. Gastrointest. Liver. Physiol. 288, G407-G416
23. Braz, J. C., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T. F., Lorenz, J. N., Nairn, A. C., Liggett, S. B., et al. (2004) PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248-254
24. Iwata, K., Luo, J., Penn, R. B., and Benovic, J. L. (2005) Bimodal regulation of the human H1 histamine receptor by G protein-coupled receptor kinase 2. J. Biol. Chem. 280, 2197-2204
25. Hosey, M. M., Benovic, J. L., DebBurman, S. K., and Richardson, R. M. (1995) Multiple mechanisms involving protein phosphorylation are linked to desensitization of muscarinic receptors. Life. Sci. 56, 951-955
26. Willets, J. M., Challiss, R. A., Kelly, E., and Nahorski, S. R. (2001) G protein-coupled receptor kinases 3 and 6 use different pathways to desensitize the endogenous M3 muscarinic acetylcholine receptor in human SH-SY5Y cells. Mol. Pharmacol. 60, 321-330
27. Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., and Lin, F. T. (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286, 2495-2498
28. Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J., and Caron, M. G. (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723
29. McLaughlin, J. P., Myers, L. C., Zarek, P. E., Caron, M. G., Lefkowitz, R. J., Czyzyk, T. A., Pintar, J. E., and Chavkin, C. (2004) Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J. Biol. Chem. 279, 1810-1818
30. Terman, G. W., Jin, W., Cheong, Y. P., Lowe, J., Caron, M. G., Lefkowitz, R. J., and Chavkin, C. (2004) G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br. J. Pharmacol. 141, 55-64
31. Gainetdinov, R. R., Bohn, L. M., Walker, J. K., Laporte, S. A., Macrae, A. D., Caron, M. G., Lefkowitz, R. J., and Premont, R. T. (1999) Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron. 24, 1029-1036
32. Gainetdinov, R. R., Bohn, L. M., Sotnikova, T. D., Cyr, M., Laakso, A., Macrae, A. D., Torres, G. E., Kim, K. M., Lefkowitz, R. J., Caron, M. G., and Premont, R. T. (2003) Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron. 38, 291-303
33. Von Zastrow, M. (2004) A cell biologist's perspective on physiological adaptation to opiate drugs. Neuropharmacology. 47, Suppl. 1, 286-292
34. Shenoy, S. K., and Lefkowitz, R. J. (2005) Seven-transmembrane receptor signaling through beta-arrestin (Online). Sci. STKE. 2005, cm10
35. Premont, R. T. (2005) Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity. Neuromolecular. Med. 7, 129-147
36. Milligan, G., and White, J. H. (2001) Protein-protein interactions at G-protein-coupled receptors. Trends. Pharmacol. Sci. 22, 513-518
37. Dorn, G. W., 2nd, and Mochly-Rosen, D. (2002) Intracellular transport mechanisms of signal transducers. Annu. Rev. Physiol. 64, 407-429